The average small cap score is 53.77, below the four week moving average score of 53.89.

ARWR today announced that it recently filed an application for approval to begin a Phase 1 clinical trial of its RNAi-based therapeutic candidate.TPIV. is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida.

The average small cap score is 54.59, above the four week moving average score of 53.22. The average small cap is trading -27.26% below its 52 week high, 0.86% above its 200 dma, and has 9.05 days to cover held short.

The average small cap score is 56.11, above the four week moving average score of 51.12.

GlobeImmune IPO’d in June to little fanfare and has underperformed the biotech sector considerably since then. A key driving event in the next six months should put it back on the radar.

The average small cap score is 46.22 this week, below the four week moving average score of 48.59. The average small cap is trading -32.93% below its 52 week high, -10.40% below its 200 dma, and has 10.50 days to cover held short. Short interest is near historically actionable levels.